Mechanochemical and Low‐Temperature Synthesis of Nanocrystalline Fluorohydroxyapatite/Fluorapatite
Source abstract
Abstract
Low‐temperature synthesis of fluorapatite/fluorohydroxyapatite with precursor mixture previously mechanochemically treated is described in this article. Ethylene vinylacetate/versatate copolymer as a surface active substance was mechanically treated to obtain a core‐shell system with strongly controlled grain size. Despite usual behavior of mechanically activated systems, only an amorphous phase formed from precursor ions present in the mixture composed of β ‐ Ca 2 P 2 O 7 , CaCO 3 , CaF 2 , and unreacted Ca ( OH ) 2 was obtained during milling for 5 min to 8 h. The mixture contained depots of labile F − ions conserved in micelles cages, which are useful for teeth protection from carries. For transformation of these amorphous phases into fluorapatite, an additional low thermal treatment was necessary. The mechanism of the precursor mixture transformation into fluorapatite during milling and thermal treatment was investigated using FTIR spectroscopy and X‐ray diffraction. The morphology and size distribution of the obtained powders was studied using SEM and TEM .
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental materials and restorations · Advanced materials and composites
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
The Vinca Institute of Nuclear Sciences Laboratory of Radiation Chemistry and Physics, University of Belgrade Mike Petrovića Alasa 12–14, P.O. Box 522 Belgrade Serbia
SGL Carbon Meitingen Germany
References (34)
Show source-provided references
1. 10.1016/j.stam.2004.02.01210.1016/j.stam.2004.02.012 ↗
2. 10.1016/j.jssc.2004.03.02410.1016/j.jssc.2004.03.024 ↗
3. 10.1007/s10856-009-3875-110.1007/s10856-009-3875-1 ↗
4. 10.1016/j.matchemphys.2007.08.02910.1016/j.matchemphys.2007.08.029 ↗
5. 10.1016/j.solidstatesciences.2010.07.01710.1016/j.solidstatesciences.2010.07.017 ↗
6. 10.1016/j.biomaterials.2003.09.10410.1016/j.biomaterials.2003.09.104 ↗
7. 10.1016/j.biomaterials.2003.09.07410.1016/j.biomaterials.2003.09.074 ↗
8. 10.1002/jbm.b.2002710.1002/jbm.b.20027 ↗
9. 10.1016/j.biomaterials.2004.07.06210.1016/j.biomaterials.2004.07.062 ↗
10. 10.1016/j.biomaterials.2005.03.04110.1016/j.biomaterials.2005.03.041 ↗
11. 10.1016/j.materresbull.2005.04.00510.1016/j.materresbull.2005.04.005 ↗
12. 10.3109/0001635880900478610.3109/00016358809004786 ↗
13. Effect of Fluoride Addition on Ionized Calcium in Salivary Sediment and in Saliva
14. 10.1177/00220345900690S15010.1177/00220345900690S150 ↗
15. 10.1016/j.ceramint.2009.01.01210.1016/j.ceramint.2009.01.012 ↗
16. 10.1016/j.ceramint.2011.02.02510.1016/j.ceramint.2011.02.025 ↗
17. 10.1159/00026121810.1159/000261218 ↗
18. 10.1023/A:102634241426210.1023/A:1026342414262 ↗
19. 10.1159/00026140010.1159/000261400 ↗
20. 10.1177/0022034592071003050110.1177/00220345920710030501 ↗
21. 10.1177/0022034500079004160110.1177/00220345000790041601 ↗
22. 10.1159/00005787210.1159/000057872 ↗
23. 10.1359/jbmr.2003.18.10.189710.1359/jbmr.2003.18.10.1897 ↗
24. 3rd Clinical Trial of Fluoride Therapy in Postmenopausal Osteoporotic Women: Extended Observations and Additional Analysis10.1002/jbmr.5650090216 ↗
25. 10.1007/s00198007005110.1007/s001980070051 ↗
26. 10.1016/S8756-3282(00)00303-310.1016/S8756-3282(00)00303-3 ↗
27. 10.1016/S8756-3282(98)00058-110.1016/S8756-3282(98)00058-1 ↗
28. 10.1016/j.biomaterials.2008.12.00710.1016/j.biomaterials.2008.12.007 ↗
29. 10.1016/j.powtec.2011.01.02010.1016/j.powtec.2011.01.020 ↗
30. 10.1016/S0022-2860(98)00586-910.1016/S0022-2860(98)00586-9 ↗
31. 10.1021/ie801275g10.1021/ie801275g ↗
32. 10.1016/j.polymdegradstab.2005.01.01110.1016/j.polymdegradstab.2005.01.011 ↗
33. 10.1016/S0167-577X(03)00498-110.1016/S0167-577X(03)00498-1 ↗
34. 10.1590/S0103-5053200600040001610.1590/S0103-50532006000400016 ↗